Meral Kayikcioglu/
Dec 3, 2025, 02:29
Meral Kayikcioglu: Successfully Completing FDA Inspections for Two Phase 3 Trials
Meral Kayikcioglu, Professor of Cardiology at Ege University and Director of the Lipid and Prevention Clinic, shared on LinkedIn:
“We successfully completed FDA inspections for two different Phase 3 RCTs (LIB-HoFH and HeFH)! This extremely challenging and prestigious inspection in pharmaceutical R&D processes also demonstrated our compliance with global standards.
To my knowledge, only 10 FDA inspections have been conducted in our country to date. Successfully passing one of these inspections is a source of great pride for both our team and our country. I thank all my teammates and stakeholders who contributed to this process.
We continue to work for stronger, more innovative, and more reliable science!”

Stay updated with Hemostasis Today.
-
Sep 29, 2026, 22:45Victor Agunyego: Paracetamol – The Most Common Drug We Underestimate
-
Sep 29, 2026, 22:42Nova Sinclair: Advancing the Future of Hematology – Meet Our 2027 Organizing Committee
-
Sep 29, 2026, 22:41Lorenz Räber: Intracoronary Imaging in PCI – Why, When, How, and Which Modality?
-
Sep 29, 2026, 22:31Selma Turkovic: Pleased to Deliver the Opening Presentation at Kingston Hospital
-
Sep 29, 2026, 22:31Miguel Teran: Ultrasound and Simulation in Arterial Blood Sampling
-
Sep 29, 2026, 21:47Javed Anees: DADA2 – When a Young Stroke Is More Than a Stroke
-
Sep 29, 2026, 22:28Mohammad Refaei: Navigating Your Career in Hematology From Training to Practice
-
Sep 29, 2026, 22:27Matteo Foschi: 10 Clinical Pearls for Antithrombotic Therapy in Secondary Stroke Prevention
-
Sep 29, 2026, 22:26A Global Call for Action on Cardiovascular Health on World Heart Day – ISTH